Suppression of experimental autoimmune encephalomyelitis by gallium nitrate
- 1 July 1992
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 39 (1-2) , 175-181
- https://doi.org/10.1016/0165-5728(92)90186-o
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Lymphocyte Proliferation Is Controlled by both Iron Availability and Regulation of Iron Uptake PathwaysPathobiology, 1992
- Use of gallium to treat Paget's disease of bone: a pilot studyThe Lancet, 1990
- Vaccination Against Experimental Allergic Encephalomyelitis with T Cell Receptor PeptidesScience, 1989
- Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitisNature, 1989
- Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic proteinCellular Immunology, 1988
- Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells. Mechanisms responsible for the specific cytotoxicity of transferrin-gallium.Journal of Clinical Investigation, 1986
- Reversal of Experimental Allergic Encephalomyelitis with Monoclonal Antibody to a T-Cell Subset MarkerScience, 1985
- Anti I-A antibody suppresses active encephalomyelitis: treatment model for diseases linked to IR genes.The Journal of Experimental Medicine, 1983
- The rapid isolation of clonable antigen‐specific T lymphocyte lines capable of mediating autoimmune encephalomyelitisEuropean Journal of Immunology, 1981
- Cyclophosphamide: Effect on Experimental Allergic Encephalomyelitis in Lewis RatsScience, 1969